drugset / Trial / NCT05076110

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

NCT05076110

Phase 4 Completed 86 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Timeline

Start
2022-04-07
Primary completion
2025-10-25
Completion
2025-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg
Subject Gabapentin Small molecule 300 mg
Subject Ibuprofen Small molecule 800 mg
Subject Methocarbamol Small molecule 500 mg
Comparator Oxycodone Other / unclassified 5 mg

Indications

No indication recorded.